SPPI - Spectrum Pharmaceuticals rises defying a series of insider selling

JuSun/iStock via Getty Images After three consecutive days of losses, the small-cap company Spectrum Pharmaceuticals ([[SPPI]] +1.8%) is on the rise in morning hours despite a string of insider selling of its common stock in recent days. Since June 17, the company insiders have offloaded ~38.2K of company shares in four different transactions with a combined valuation of $161.9K. Today, Henderson, Nevada-based Spectrum announced the voting results from its 2021 annual stockholders meeting which was held on June 07. The shareholders have approved the compensation of the named executive officers and elected seven nominees to the board for one year term, according to the 8-K filing submitted by the company. Avisol Capital Partners “is not any great believer in the long-term prospects” of Spectrum, the Seeking Alpha contributor says with a neutral rating on the stock.

For further details see:

Spectrum Pharmaceuticals rises defying a series of insider selling